Posted on 16/08/08
Stada surges on report of possible Teva bid
Stada Arzneimittel AG gained the most in three years after Israel's Globes newspaper said Teva Pharmaceutical Industries Ltd. is in talks to acquire Germany's third-largest generic-drug maker. In April, the Israeli drug maker's European head Gerard van Odijk said Teva had examined the option of acquiring Stada. Teva last month announced a plan to acquire Barr Pharmaceuticals Inc. for $7.46-billion (U.S.). Stada spokesman Axel Mueller said the Bad Vilbel-based company never comments on market rumours. Teva spokeswoman Ayala Miller didn't return a telephone call requesting comment. SAZ (Frankfurt) rose €3.75 to €36.30 ($56.41).
The full text of this article has 106 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
